The company may be sacrificing current earnings per share to...
The company may be sacrificing current earnings per share to drive growth. The modest 1.2% dividend yield is unlikely to be attracting many buyers. The company's future earnings are worth investigating, especially considering the strong total shareholder return over the past five years.
Despite the Downward Trend in Earnings at Lushang Freda PharmaceuticalLtd (SHSE:600223) the Stock Climbs 5.4%, Bringing Five-year Gains to 157%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment